Nacho Aguiló

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial

François Spertini, R Audran, Reza Chakour et al. · The Lancet Respiratory Medicine · 2015 · 175 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

<i>K</i><i>lebsiella pneumoniae</i>survives within macrophages by avoiding delivery to lysosomes

Victoria Cano, Catalina March, José Luis Insua et al. · Cellular Microbiology · 2015 · 151 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson et al. · The Lancet Respiratory Medicine · 2019 · 137 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17–Dependent Mechanism

Nacho Aguiló, Samuel Álvarez-Arguedas, Santiago Uranga et al. · The Journal of Infectious Diseases · 2015 · 136 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis

Nacho Aguiló, Jesús Gonzalo‐Asensio, Samuel Álvarez-Arguedas et al. · Nature Communications · 2017 · 136 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17